...
首页> 外文期刊>Journal of vascular surgery >Measurement of walking endurance and walking velocity with questionnaire: validation of the walking impairment questionnaire in men and women with peripheral arterial disease.
【24h】

Measurement of walking endurance and walking velocity with questionnaire: validation of the walking impairment questionnaire in men and women with peripheral arterial disease.

机译:用问卷测量步行耐力和步行速度:男性和女性患有外周动脉疾病的步行障碍问卷的验证。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVES: The Walking Impairment Questionnaire (WIQ) was designed to measure community walking ability in patients with peripheral arterial disease (PAD) and intermittent claudication. We compared the WIQ scores to objective measures of walking in a heterogeneous group of patients with and without PAD. METHODS: The study was designed as a cross-sectional study, with the setting in an academic medical center. The subjects were patients with PAD (n = 145) who were identified from a noninvasive vascular laboratory at an academic medical center. The patients without PAD (n = 65) were identified from a general medicine practice. The average number of comorbidities was 2.03 for patients with PAD and 1.52 for patients without PAD. Among the patients with PAD, 28% had classical intermittent claudication symptoms and 55% had exertional leg symptoms other than claudication. The main outcome measures were the WIQ estimates of the patient-reported walking distance and walking speed on a scale of 0 to 100. Walking endurance was measured objectively with the 6-minute walk. Walking velocity was measured with a 4-m walk. PAD and PAD severity were defined with the ankle brachial index. RESULTS: The Spearman rank correlation coefficients (rho) between the WIQ distance score and the 6-minute walk score were 0.557 among patients with PAD (P <.001) and 0.484 among patients without PAD (P <.001). The correlation coefficients between the WIQ speed score and the usual-paced 4-m walk score were 0.528 among patients with PAD (P <.001) and 0.524 among patients without PAD (P <.001). The correlations were not affected by the presence versus the absence of intermittent claudication, by PAD severity, or by the presence of 2 or more versus less than 2 comorbid illnesses. The WIQ scores in the highest and lowest quartiles were the most closely associated with the objective measures of function. CONCLUSION: The WIQ is a valid measure of community walking ability in a heterogeneous group of patients with and without PAD. The WIQ discriminates best among patients in the highest and the lowest quartiles of walking speed and endurance.
机译:目的:步行障碍调查表(WIQ)旨在测量周围动脉疾病(PAD)和间歇性lau行患者的社区步行能力。我们将WIQ得分与客观组在有或没有PAD的异类患者中行走的情况进行了比较。方法:研究设计为横断面研究,设置在学术医学中心。研究对象是从学术医学中心的无创血管实验室中鉴定出的PAD患者(n = 145)。无PAD的患者(n = 65)是根据一般医学实践确定的。 PAD患者的平均合并症数为2.03,而无PAD患者的平均合并症数为1.52。在患有PAD的患者中,有28%患有典型的间歇性lau行症状,而55%的患者有exert行以外的劳累腿症状。主要的结局指标是患者报告的步行距离和步行速度的WIQ估计值,范围为0至100。步行耐力是在6分钟的步行路程内客观测量的。以4-m的步行量来测量步行速度。 PAD和PAD严重程度由踝肱指数定义。结果:WIQ距离评分和6分钟步行评分之间的Spearman等级相关系数(rho)在PAD患者中为0.557(P <.001),在无PAD患者中为0.484(P <.001)。 PAD患者中WIQ速度得分与通常节奏的4米步行得分之间的相关系数为0.528(P <.001),而无PAD患者则为0.524(P <.001)。相关性不受间歇性lau行的存在与否,PAD严重性或两种或两种以上(少于2种)合并症的影响。最高和最低四分位数中的WIQ得分与功能的客观指标最密切相关。结论:WIQ是衡量PAD与非PAD异种患者社区行走能力的有效指标。 WIQ在步行速度和耐力的最高和最低四分位数之间对患者进行最佳区分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号